SHENGDA BIO-PHARM and others established a technology company including retail business for publications
According to the Qichacha APP, recently, Tiantai Miaoxin Technology Co., Ltd. was established, with Fang Xin as the legal representative and a registered capital of 1 million yuan. The business scope includes: internet sales of publications; retail of publications; basic telecommunications services; second-class value-added telecommunications services, etc. Qichacha's equity penetration shows that the company is jointly held by SHENGDA BIO-PHARM and others
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments